Tinted Sunscreen for Melasma: Color Readings and Severity Scores

If you are choosing a tinted sunscreen for facial patches during GLP-1 treatment, ask what the supporting study measured. A color instrument, a clinician's severity score and a percentage improvement do not describe the same outcome.

The five-month trial compared similar UV protection

A 2025 randomized, investigator-blinded study recruited 42 women with melasma in southern France. They were aged 28 to 58, with skin phototypes III or IV. Participants used tinted or untinted sunscreen at least twice daily for five months; 41 completed follow-up. UV protection was similar. The tinted product contained iron oxides and pigmentary titanium dioxide. [1]

Measurements were taken before cream application. Instrument readings showed reduced contrast between melasma and adjacent skin in the tinted group compared with its starting values. The modified Melasma Area and Severity Index, or mMASI, decreased from 4.0 to 3.5 with tint and 4.1 to 3.2 without tint, with no significant difference between groups. [1]

The report notes baseline imbalances. NAOS funded the study, and three authors were current or former company employees. Its instrument findings should not be presented as proof of superior clinician-rated severity improvement. [1]

The earlier trial also used a pigment medicine

In a 2014 double-blind trial, 68 people with melasma were randomized to UV-plus-visible-light sunscreen containing iron oxide or UV-only sunscreen. Both had SPF of at least 50, and everyone received 4% hydroquinone. Sixty-one completed eight weeks. [2]

The abstract reports greater improvements with the UV-plus-visible-light formula: 15% for the MASI severity score, 28% for colorimetry and 4% for melanin assessment. Those are three separate comparisons. They do not mean 15% of users were cured or every person's patches faded by 28%. [2]

Because both groups received hydroquinone, this study cannot supply a sunscreen-only clearing rate. It also does not establish that every tinted product will perform like the tested formula. Neither trial establishes a GLP-1-specific treatment effect.

Choose a formula you can apply consistently

Take your current sunscreen and its ingredient list to the dermatologist. Discuss the tint on your own skin, the amount you apply and whether the finish leads you to use less. Photograph the packaging so the clinician can identify the formula rather than relying on a shade name.

AAD advises applying sunscreen 15 minutes before going outside and reapplying at least every two hours. Seek shade and wear a wide-brimmed hat. Its melasma advice also favors gentle, fragrance-free skin care: burning or stinging signals irritation that may darken spots. [3]

Bring a product claim to the appointment with its study link. Ask the clinician to identify the tested formula, any accompanying treatment and the outcome behind the quoted percentage. You can then discuss whether that evidence fits the change you hope to see.

Start with the melasma sunscreen-planning guide. If your routine includes foundation, read the study on SPF foundation and application amount.

Printed book

How to Keep Your Face on GLP-1

$12.95 + free shipping

Order Now

✓ 30 day money back guarantee

This article provides general education, not a diagnosis or an individual treatment plan. Medication information refers to US sources. Discuss medication, nutrition and cosmetic treatment decisions with qualified clinicians.